肝癌的主要治疗方法为手术治疗、局部或全身化疗等,尽管患者的长期生存率有所提高,但术后5年存活率仍在43%~61%。为预防复发、治疗不能手术切除或不能耐受化疗的患者,生物治疗成为继手术、放疗和化疗后肿瘤治疗的第四模式,其中免疫治疗已成为关注的焦点。开展肿瘤 The main treatment for liver cancer is surgical treatment, local or systemic chemotherapy, although the long-term survival rate of patients has increased, but the survival rate after 5 years is still 43% to 61%. In order to prevent relapse and treat patients who can not be surgically removed or can not tolerate chemotherapy, biotherapy becomes the fourth mode of tumor treatment after surgery, radiotherapy and chemotherapy, and immunotherapy has become the focus of attention. To carry out the tumor